Nicholas Downing - 29 Dec 2023 Form 3 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ Nicholas Downing
Issuer symbol
NAMS
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
3
Filing time
29 Dec 2023, 17:04:20 UTC
Next filing
07 Aug 2025

No securities are beneficially owned.